Marshall Fordyce, M.D.

Marshall Fordyce, M.D., is the Chief Executive Officer and Founder of Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative treatments for autoimmune diseases and kidney disorders. He holds a medical degree from Harvard Medical School, which underscores his strong academic background in the life sciences and medicine.

Prior to founding Vera Therapeutics, Dr. Fordyce has been involved in various roles within the biotech industry, contributing significantly to advancements in therapeutic approaches. His leadership at Vera Therapeutics emphasizes the development of biologics aimed at treating conditions such as IgAN (IgA nephropathy), a serious kidney disease.

In addition to his executive role, Fordyce is active in discussions surrounding the biotech field, often engaging in interviews and panels that address challenges and innovations within the industry. His insights are regularly shared through platforms like LinkedIn, where he discusses topics related to biotechnology and healthcare advancements.123